Philippines Is Negotiating for 178 Million Coronavirus Vaccine Doses
(Bloomberg) -- Philippine President Rodrigo Duterte pledged to keep the economy afloat amid the coronavirus pandemic as his administration raced to secure vaccines enough for most of its adult population.
“We are sinking deeper and deeper,” Duterte said in a live-streamed briefing on Monday night. “We are trying our very best to keep us afloat.” The Southeast Asian nation's gross domestic product contracted by 9.5% in 2020, the most since 1946.
The Philippines, which has the second-highest number of coronavirus infections in the region, is negotiating for 178 million coronavirus vaccine doses, enough to inoculate 92 million people, Finance Secretary Carlos Dominguez said in the same briefing.
The amount is more than the target of 148 million doses this year as it takes into account delays in order delivery, Dominguez said. The government has secured $1.4 billion of funding from multilateral agencies, he said.
About 3 million doses will arrive in February and the bulk in the third and fourth quarters, said Carlito Galvez, who leads the vaccination program. The government targets to ink more supply deals this month after signing term sheets with five manufacturers to lock in about 108 million doses, Galvez said at a televised briefing Tuesday.
China can start shipping Sinovac Biotech Ltd. vaccines that it will donate to the Philippines once the Food and Drug Administration approves the manufacturer's application for emergency use, Galvez said.
The government will prioritize health care workers and uniformed personnel this quarter, and economic frontliners such as drivers and food services personnel in the second quarter. The Philippines has more than 520,000 coronavirus cases as of February 1.
Duterte said the vaccine race has turned into a competition among the highest bidders. It's not easy for Southeast Asian nations to secure shots because they are “not as really as powerful as” the European Union, he said.
Read: Philippines to Receive 5.6 Million Vaccine Doses This Quarter
©2021 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
Why Prashant Jain's 3P Investment Managers Bought 2.5% Stake In This Healthcare Firm
After slowing acquisitions, Entero now has the opportunity to extract greater value from the network. The key, however, will be execution.
-
Taxing A Promise: The Unsettled Story Of GST On Corporate Guarantees
These concerns are particularly relevant for businesses in the infrastructure, real estate, power and EPC sectors, where guarantees run for several years over the duration of the project and involve substantial amounts.
-
Who Will Care When Women Work? That Is The Wrong Question
The debate on women and work becomes strangely patronising when even our most enlightened elites assume that care is a woman's natural duty.
-
AI Disruption Is Exponential, Businesses Need A Margin Of Safety: HDFC AMC's Navneet Munot
According to Munot, one of the biggest challenges in assessing AI's impact is that the pace of change is exponential rather than linear.
-
The AI Race Is Bigger Than AI Models | The Week In Whys
The AI race and the humanoid race may look like two different technology stories. But underneath, they are increasingly about the same thing: who controls the ecosystem needed to build the technology.
-
FCNR Deposits Beat Estimates, RBI To Pull Out Rs 6-7 Lakh Crore: Pranjul Bhandari
HSBC's chief India economist says the central bank must drain up to Rs 7 lakh crore of surplus liquidity within a fortnight, either through a cash reserve ratio hike or dollar sales, as Foreign Currency Non-Resident (Bank) deposits far outpace expectations
-
Joining The Dots | CAS Turmoil, The Large-Cap Debate And Zee's Almost Rs 22,000-Crore Haircut
Time bends on Dalal Street, Dylan's lyrics haunt the large-cap debate, and Zee's promoter picks up the bargain of the year.